Categories Earnings, Health Care

Earnings Summary: Organon reports financial results for Q1 2024

Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and adjusted earnings for the first quarter of 2024.

  • First-quarter revenue was $1.62 billion, which is up 5% on a reported basis and 7% at constant currency
  • Women’s Health revenue increased by 11% and Biosimilars revenue climbed by 46%
  • Meanwhile, Established Brands revenue was flat on an as-reported basis during the quarter
  • Reported earnings per share and adjusted earnings per share were $0.78 and $1.22, respectively, during the three months
  • Net income came in at $201 million in the March quarter and adjusted EBITDA was $538 million
  • Gross margin was 59.0% on a reported basis and 62.1% on an adjusted basis in the first quarter
  • Adjusted EBITDA margin dropped to 33.2% in the first quarter from 33.7% last year

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Key highlights from Deere & Co.’s (DE) Q4 2024 earnings results

Deere & Company (NYSE: DE) reported its fourth quarter 2024 earnings results today. Worldwide net sales and revenues decreased 28% year-over-year to $11.14 billion. Net income was $1.24 billion, or

NVDA Earnings: Nvidia Q3 profit jumps, beats estimates

NVIDIA Corporation (NASDAQ: NVDA) on Wednesday reported a sharp increase in adjusted profit and revenue for the third quarter of 2025. Earnings also topped analysts' estimates. The tech firm’s revenues

Lowe’s Companies (LOW): A few points to note about the Q3 2024 performance

Shares of Lowe’s Companies, Inc. (NYSE: LOW) rose over 1% on Wednesday. The stock has gained 8% over the past three months. The company delivered better-than-expected earnings results for the

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top